Ardelyx reported $256.19M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Amgen USD 57.3B 19M Jun/2026
Ardelyx USD 256.19M 47.93M Jun/2026
aTyr Pharma USD 2.28M 478K Jun/2026
Corcept Therapeutics USD 8.99M 430K Sep/2026
Curis USD 0 0 Jun/2022
Sanofi EUR 23.58B 3.56B Jun/2026
TG Therapeutics USD 754.37M 68K Sep/2026
United Therapeutics USD 200M 100M Mar/2025